Intimation of incorporation of a new wholly owned subsidiary.

August 13, 2026 To To Listing Department, The Corporate Relations Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED Exchange Plaza, Phiroz Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (E), 25th floor, Dalal Street, MUMBAI -400 051 MUMBAI -400 001 Company Code No. AUROPHARMA Company Code No. 524804 Dear Sir / Madam, Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is to inform you that the Company has incorporated a new wholly owned subsidiary company by the name of ‘Auropharm Overseas Limited’ in India. The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, is attached as ‘Annexure A’. This is for your information and records. Yours faithfully, For AUROBINDO PHARMA LIMITED B. Adi Reddy Company Secretary Enclosures: Annexure A Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038 Telangana., India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833 Email: info@aurobindo.com Website: www.aurobindo.com Annexure ·A Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 a) Name of the target entity, details in brief such Name: Auropharm Overseas Limited as size, turnover etc.; Turnover: Not applicable as the company was incorporated on August 13, 2026. b) Whether the acquisition would fall within Auropharm Overseas Limited is incorporated as a related party transaction(s) and whether the wholly owned subsidiary of the Company and therefore promoter / promoter group / group companies is a related party of the Company. Promoters and have any interest in the entity being acquired? If promoter group of the Company are not interested in yes, nature of interest and details thereof and the transaction whether the same is done at "arms-length"; c) Industry to which the business of the target Pharmaceuticals entity being acquired belongs; d) Objects and effects of acquisition (including The object of incorporation of this wholly owned but not limited to, disclosure of reasons for subsidiary is to undertake manufacturing and marketing acquisition of target entity, if its business is operations in India and foreign countries. outside the main line of business of the listed entity); e) Brief details of any governmental or regulatory No governmental or regulatory approvals required. approvals required for the acquisition. f) Indicative time period for completion of the Not applicable acquisition. g) Nature of consideration - whether cash 100% subscription to the share capital in cash consideration or share swap or any other form and details of the same; h) Cost of acquisition and / or the price at which Initial subscription to the share capital of Rs. 10,00,000 the shares are acquired; New Subsidiary was divided into 1,00,000 equity shares of RS.10 each. incorporated. i) Percentage of shareholding / control acquired 100% and or number of shares acquired; j) Brief background about the entity acquired in This is a newly incorporated company and therefore the terms of products/line of business acquired, date history of the last 3 years’ turnover is not available. of incorporation, history of last 3 years turnover, country in which the acquired entity has Auropharm Overseas Limited is incorporated on August presence and any other significant information 13, 2026 in India. (in brief); Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038 Telangana., India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833 Email: info@aurobindo.com Website: www.aurobindo.com